This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piskurich, J. F.
Right arrow Articles by Ting, J. P.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piskurich, J. F.
Right arrow Articles by Ting, J. P.-Y.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, January 1999, p. 431-440, Vol. 19, No. 1
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Two Distinct Gamma Interferon-Inducible Promoters of the Major Histocompatibility Complex Class II Transactivator Gene Are Differentially Regulated by STAT1, Interferon Regulatory Factor 1, and Transforming Growth Factor beta

Janet F. Piskurich, Michael W. Linhoff, Ying Wang, and Jenny P.-Y. Ting*

Lineberger Comprehensive Cancer Center and Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Received 11 August 1998/Returned for modification 9 September 1998/Accepted 28 September 1998

The major histocompatibility complex (MHC) class II transactivator (CIITA) is the master regulatory factor required for appropriate expression of class II MHC genes. Understanding the expression of CIITA is key to understanding the regulation of class II MHC genes. This report describes the independent regulation of two distinct CIITA promoters by cytokines with opposing functions, gamma interferon (IFN-gamma ) and transforming growth factor beta  (TGF-beta ). A functional analysis of deletion mutations of the upstream promoter (promoter III) identified an IFN-gamma -responsive region located approximately 5 kb from the transcriptional start site. An in vivo DNase I hypersensitivity analysis detected a hypersensitive site in this area which supports the relevance of this region. When the downstream promoter (promoter IV) was studied by in vivo genomic footprinting, IFN-gamma -induced changes at putative binding sites for STAT1, interferon regulatory factor 1 (IRF-1), and E-box proteins were seen. Gel shift and supershift analyses for IRF-1 confirmed the in vivo footprint results. The role of the IFN-gamma -inducible transcription factor STAT1 was examined functionally. Although both promoters were controlled by STAT1, promoter-specific regulation was exhibited. The IFN-gamma response of promoter III was completely dependent on STAT1 and not IRF-1, while promoter IV was partially activated by IRF-1 in the total absence of STAT1 expression. While both promoters were affected by TGF-beta , activation of promoter III by IFN-gamma was more severely diminished by TGF-beta treatment. The differential control of CIITA promoters by TGF-beta , IRF-1, and STAT1 may be important in refining regulation of class II MHC genes in different cell types and under different stimulatory conditions.

* Corresponding author. Mailing address: Lineberger Comprehensive Cancer Center, Department of Microbiology and Immunology, CB 7295, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599. Phone: (919) 966-5538. Fax: (919) 966-3015. E-mail: panyun{at}med.unc.edu.

Molecular and Cellular Biology, January 1999, p. 431-440, Vol. 19, No. 1
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Choi, J. C., Holtz, R., Murphy, S. P. (2009). Histone Deacetylases Inhibit IFN-{gamma}-Inducible Gene Expression in Mouse Trophoblast Cells. J. Immunol. 182: 6307-6315 [Abstract] [Full Text]  
  • Arakaki, R., Nagaoka, A., Ishimaru, N., Yamada, A., Yoshida, S., Hayashi, Y. (2009). Role of Plasmacytoid Dendritic Cells for Aberrant Class II Expression in Exocrine Glands from Estrogen-Deficient Mice of Healthy Background. Am. J. Pathol. 174: 1715-1724 [Abstract] [Full Text]  
  • Debierre-Grockiego, F., Molitor, N., Schwarz, R. T., Luder, C. G.K. (2009). Toxoplasma gondii glycosylphosphatidylinositols up-regulate major histocompatibility complex (MHC) molecule expression on primary murine macrophages. Innate Immunity 15: 25-32 [Abstract]  
  • Liu, Y., Li, P., Lu, J., Xiong, W., Oger, J., Tetzlaff, W., Cynader, M. (2008). Bilirubin Possesses Powerful Immunomodulatory Activity and Suppresses Experimental Autoimmune Encephalomyelitis. J. Immunol. 181: 1887-1897 [Abstract] [Full Text]  
  • Bewry, N. N., Bolick, S. C. E., Wright, K. L., Harton, J. A. (2007). GTP-dependent Recruitment of CIITA to the Class II Major Histocompatibility Complex Promoter. J. Biol. Chem. 282: 26178-26184 [Abstract] [Full Text]  
  • Zhao, W., Cha, E. N., Lee, C., Park, C. Y., Schindler, C. (2007). Stat2-Dependent Regulation of MHC Class II Expression. J. Immunol. 179: 463-471 [Abstract] [Full Text]  
  • Choi, J. C., Holtz, R., Petroff, M. G., Alfaidy, N., Murphy, S. P. (2007). Dampening of IFN-{gamma}-Inducible Gene Expression in Human Choriocarcinoma Cells Is Due to Phosphatase-Mediated Inhibition of the JAK/STAT-1 Pathway. J. Immunol. 178: 1598-1607 [Abstract] [Full Text]  
  • Kohoutek, J., Blazek, D., Peterlin, B. M. (2006). Hexim1 sequesters positive transcription elongation factor b from the class II transactivator on MHC class II promoters. Proc. Natl. Acad. Sci. USA 103: 17349-17354 [Abstract] [Full Text]  
  • Clements, C. M., McNally, R. S., Conti, B. J., Mak, T. W., Ting, J. P.-Y. (2006). DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl. Acad. Sci. USA 103: 15091-15096 [Abstract] [Full Text]  
  • Tooze, R. M., Stephenson, S., Doody, G. M. (2006). Repression of IFN-{gamma} Induction of Class II Transactivator: A Role for PRDM1/Blimp-1 in Regulation of Cytokine Signaling. J. Immunol. 177: 4584-4593 [Abstract] [Full Text]  
  • Yao, Y., Xu, Q., Kwon, M.-J., Matta, R., Liu, Y., Hong, S.-C., Chang, C.-H. (2006). ERK and p38 MAPK Signaling Pathways Negatively Regulate CIITA Gene Expression in Dendritic Cells and Macrophages. J. Immunol. 177: 70-76 [Abstract] [Full Text]  
  • Pennini, M. E., Pai, R. K., Schultz, D. C., Boom, W. H., Harding, C. V. (2006). Mycobacterium tuberculosis 19-kDa Lipoprotein Inhibits IFN-{gamma}-Induced Chromatin Remodeling of MHC2TA by TLR2 and MAPK Signaling. J. Immunol. 176: 4323-4330 [Abstract] [Full Text]  
  • Buttice, G., Miller, J., Wang, L., Smith, B. D. (2006). Interferon-{gamma} Induces Major Histocompatibility Class II Transactivator (CIITA), Which Mediates Collagen Repression and Major Histocompatibility Class II Activation by Human Aortic Smooth Muscle Cells. Circ. Res. 98: 472-479 [Abstract] [Full Text]  
  • Shang, L., Tomasi, T. B. (2006). The Heat Shock Protein 90-CDC37 Chaperone Complex Is Required for Signaling by Types I and II Interferons. J. Biol. Chem. 281: 1876-1884 [Abstract] [Full Text]  
  • Zika, E., Fauquier, L., Vandel, L., Ting, J. P.-Y. (2005). Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-{gamma}-inducible MHC-II gene expression. Proc. Natl. Acad. Sci. USA 102: 16321-16326 [Abstract] [Full Text]  
  • Chou, S.-D., Khan, A. N. H., Magner, W. J., Tomasi, T. B. (2005). Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells. Int Immunol 17: 1483-1494 [Abstract] [Full Text]  
  • Ni, Z., Karaskov, E., Yu, T., Callaghan, S. M., Der, S., Park, D. S., Xu, Z., Pattenden, S. G., Bremner, R. (2005). Apical role for BRG1 in cytokine-induced promoter assembly. Proc. Natl. Acad. Sci. USA 102: 14611-14616 [Abstract] [Full Text]  
  • van der Stoep, N., Quinten, E., Rezende, M. M., van den Elsen, P. J. (2004). E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII). Blood 104: 2849-2857 [Abstract] [Full Text]  
  • Xu, Y., Wang, L., Buttice, G., Sengupta, P. K., Smith, B. D. (2004). Major Histocompatibility Class II Transactivator (CIITA) Mediates Repression of Collagen (COL1A2) Transcription by Interferon {gamma} (IFN-{gamma}). J. Biol. Chem. 279: 41319-41332 [Abstract] [Full Text]  
  • Greer, S. F., Harton, J. A., Linhoff, M. W., Janczak, C. A., Ting, J. P.-Y., Cressman, D. E. (2004). Serine Residues 286, 288, and 293 within the CIITA: A Mechanism for Down-Regulating CIITA Activity through Phosphorylation. J. Immunol. 173: 376-383 [Abstract] [Full Text]  
  • Holling, T. M., Schooten, E., Langerak, A. W., van den Elsen, P. J. (2004). Regulation of MHC class II expression in human T-cell malignancies. Blood 103: 1438-1444 [Abstract] [Full Text]  
  • Tzortzakaki, E., Spilianakis, C., Zika, E., Kretsovali, A., Papamatheakis, J. (2003). Steroid Receptor Coactivator 1 Links the Steroid and Interferon {gamma} Response Pathways. Mol. Endocrinol. 17: 2509-2518 [Abstract] [Full Text]  
  • Takeuchi, O., Sims, T. N., Takei, Y., Ramassar, V., Famulski, K. S., Halloran, P. F. (2003). Differential Usage of Class II Transactivator Promoters PI and PIV during Inflammation and Injury in Kidney. J. Am. Soc. Nephrol. 14: 2823-2832 [Abstract] [Full Text]  
  • Hornell, T. M. C., Beresford, G. W., Bushey, A., Boss, J. M., Mellins, E. D. (2003). Regulation of the Class II MHC Pathway in Primary Human Monocytes by Granulocyte-Macrophage Colony-Stimulating Factor. J. Immunol. 171: 2374-2383 [Abstract] [Full Text]  
  • Holtz, R., Choi, J. C., Petroff, M. G., Piskurich, J. F., Murphy, S. P. (2003). Class II Transactivator (CIITA) Promoter Methylation Does Not Correlate with Silencing of CIITA Transcription in Trophoblasts. Biol. Reprod. 69: 915-924 [Abstract] [Full Text]  
  • Pai, R. K., Convery, M., Hamilton, T. A., Boom, W. H., Harding, C. V. (2003). Inhibition of IFN-{gamma}-Induced Class II Transactivator Expression by a 19-kDa Lipoprotein from Mycobacterium tuberculosis: A Potential Mechanism for Immune Evasion. J. Immunol. 171: 175-184 [Abstract] [Full Text]  
  • van den Elsen, P. J., van der Stoep, N., Yazawa, T. (2003). Class II Transactivator (CIITA) Deficiency in Tumor Cells: Complicated Mechanisms or Not?. Am. J. Pathol. 163: 373-376 [Full Text]  
  • Zika, E., Greer, S. F., Zhu, X.-S., Ting, J. P.-Y. (2003). Histone Deacetylase 1/mSin3A Disrupts Gamma Interferon-Induced CIITA Function and Major Histocompatibility Complex Class II Enhanceosome Formation. Mol. Cell. Biol. 23: 3091-3102 [Abstract] [Full Text]  
  • Waldburger, J.-M., Rossi, S., Hollander, G. A., Rodewald, H.-R., Reith, W., Acha-Orbea, H. (2003). Promoter IV of the class II transactivator gene is essential for positive selection of CD4+ T cells. Blood 101: 3550-3559 [Abstract] [Full Text]  
  • Das, S., Lin, J.-H., Papamatheakis, J., Sykulev, Y., Tsichlis, P. N. (2002). Differential Splicing Generates Tvl-1/RFXANK Isoforms with Different Functions. J. Biol. Chem. 277: 45172-45180 [Abstract] [Full Text]  
  • van der Stoep, N., Quinten, E., van den Elsen, P. J. (2002). Transcriptional Regulation of the MHC Class II Trans-Activator (CIITA) Promoter III: Identification of a Novel Regulatory Region in the 5'-Untranslated Region and an Important Role for cAMP-Responsive Element Binding Protein 1 and Activating Transcription Factor-1 in CIITA-Promoter III Transcriptional Activation in B Lymphocytes. J. Immunol. 169: 5061-5071 [Abstract] [Full Text]  
  • Murphy, S. P., Holtz, R., Lewandowski, N., Tomasi, T. B., Fuji, H. (2002). DNA Alkylating Agents Alleviate Silencing of Class II Transactivator Gene Expression in L1210 Lymphoma Cells. J. Immunol. 169: 3085-3093 [Abstract] [Full Text]  
  • Wong, A. W., Ghosh, N., McKinnon, K. P., Reed, W., Piskurich, J. F., Wright, K. L., Ting, J. P.-Y. (2002). Regulation and Specificity of MHC2TA Promoter Usage in Human Primary T Lymphocytes and Cell Line. J. Immunol. 169: 3112-3119 [Abstract] [Full Text]  
  • Barbieri, G., Deffrennes, V., Prod'homme, T., Vedrenne, J., Baton, F., Cortes, C., Fischer, A., Bono, M.-R., Lisowska-Grospierre, B., Charron, D., Alcaide-Loridan, C. (2002). Isoforms of the class II transactivator protein. Int Immunol 14: 839-848 [Abstract] [Full Text]  
  • Pai, R. K., Askew, D., Boom, W. H., Harding, C. V. (2002). Regulation of Class II MHC Expression in APCs: Roles of Types I, III, and IV Class II Transactivator. J. Immunol. 169: 1326-1333 [Abstract] [Full Text]  
  • Morris, A. C., Beresford, G. W., Mooney, M. R., Boss, J. M. (2002). Kinetics of a Gamma Interferon Response: Expression and Assembly of CIITA Promoter IV and Inhibition by Methylation. Mol. Cell. Biol. 22: 4781-4791 [Abstract] [Full Text]  
  • Storm van's Gravesande, K., Layne, M. D., Ye, Q., Le, L., Baron, R. M., Perrella, M. A., Santambrogio, L., Silverman, E. S., Riese, R. J. (2002). IFN Regulatory Factor-1 Regulates IFN-{gamma}-Dependent Cathepsin S Expression. J. Immunol. 168: 4488-4494 [Abstract] [Full Text]  
  • Stewart, M. D., Choi, Y., Johnson, G. A., Yu-Lee, L.-y., Bazer, F. W., Spencer, T. E. (2002). Roles of Stat1, Stat2, and Interferon Regulatory Factor-9 (IRF-9) in Interferon Tau Regulation of IRF-1. Biol. Reprod. 66: 393-400 [Abstract] [Full Text]  
  • Holling, T. M., van der Stoep, N., Quinten, E., van den Elsen, P. J. (2002). Activated Human T Cells Accomplish MHC Class II Expression Through T Cell-Specific Occupation of Class II Transactivator Promoter III. J. Immunol. 168: 763-770 [Abstract] [Full Text]  
  • Zhu, X.-S., Ting, J. P.-Y. (2001). A 36-Amino-Acid Region of CIITA Is an Effective Inhibitor of CBP: Novel Mechanism of Gamma Interferon-Mediated Suppression of Collagen {alpha}2(I) and Other Promoters. Mol. Cell. Biol. 21: 7078-7088 [Abstract] [Full Text]  
  • Harton, J. A., Zika, E., Ting, J. P.-Y. (2001). The Histone Acetyltransferase Domains of CREB-binding Protein (CBP) and p300/CBP-associated Factor Are Not Necessary for Cooperativity with the Class II Transactivator. J. Biol. Chem. 276: 38715-38720 [Abstract] [Full Text]  
  • Waldburger, J.-M., Suter, T., Fontana, A., Acha-Orbea, H., Reith, W. (2001). Selective Abrogation of Major Histocompatibility Complex Class II Expression on Extrahematopoietic Cells in Mice Lacking Promoter IV of the Class II Transactivator Gene. JEM 194: 393-406 [Abstract] [Full Text]  
  • Honey, K., Rudensky, A. (2001). The Piv-Otal Class II Transactivator Promoter Regulates Major Histocompatibility Complex Class II Expression in the Thymus. JEM 194: f15-f18 [Full Text]  
  • Li, G., Harton, J. A., Zhu, X., Ting, J. P.-Y. (2001). Downregulation of CIITA Function by Protein Kinase A (PKA)-Mediated Phosphorylation: Mechanism of Prostaglandin E, Cyclic AMP, and PKA Inhibition of Class II Major Histocompatibility Complex Expression in Monocytic Lines. Mol. Cell. Biol. 21: 4626-4635 [Abstract] [Full Text]  
  • Deffrennes, V., Vedrenne, J., Stolzenberg, M.-C., Piskurich, J., Barbieri, G., Ting, J. P., Charron, D., Alcaide-Loridan, C. (2001). Constitutive Expression of MHC Class II Genes in Melanoma Cell Lines Results from the Transcription of Class II Transactivator Abnormally Initiated from Its B Cell-Specific Promoter. J. Immunol. 167: 98-106 [Abstract] [Full Text]  
  • Dong, Y., Tang, L., Letterio, J. J., Benveniste, E. N. (2001). The Smad3 Protein Is Involved in TGF-{{beta}} Inhibition of Class II Transactivator and Class II MHC Expression. J. Immunol. 167: 311-319 [Abstract] [Full Text]  
  • Goodwin, B. L., Xi, H., Tejiram, R., Eason, D. D., Ghosh, N., Wright, K. L., Nagarajan, U., Boss, J. M., Blanck, G. (2001). Varying Functions of Specific Major Histocompatibility Class II Transactivator Promoter III and IV Elements in Melanoma Cell Lines. Cell Growth Differ. 12: 327-335 [Abstract] [Full Text]  
  • O'Keefe, G. M., Nguyen, V. T., Ping Tang, L., Benveniste, E. N. (2001). IFN-{{gamma}} Regulation of Class II Transactivator Promoter IV in Macrophages and Microglia: Involvement of the Suppressors of Cytokine Signaling-1 Protein. J. Immunol. 166: 2260-2269 [Abstract] [Full Text]  
  • Eason, D. D., Blanck, G. (2001). High Level Class II trans-Activator Induction Does Not Occur with Transient Activation of the IFN-{{gamma}} Signaling Pathway. J. Immunol. 166: 1041-1048 [Abstract] [Full Text]  
  • Merediz, S. A. K., Schmidt, M., Hoppe, G. J., Alfken, J., Meraro, D., Levi, B.-Z., Neubauer, A., Wittig, B. (2000). Cloning of an interferon regulatory factor 2 isoform with different regulatory ability. Nucleic Acids Res 28: 4219-4224 [Abstract] [Full Text]  
  • Goodbourn, S., Didcock, L., Randall, R. E. (2000). Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81: 2341-2364 [Full Text]  
  • Harton, J. A., Ting, J. P.-Y. (2000). Class II Transactivator: Mastering the Art of Major Histocompatibility Complex Expression. Mol. Cell. Biol. 20: 6185-6194 [Full Text]  
  • Masternak, K., Muhlethaler-Mottet, A., Villard, J., Zufferey, M., Steimle, V., Reith, W. (2000). CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 14: 1156-1166 [Abstract] [Full Text]  
  • Morris, A. C., Spangler, W. E., Boss, J. M. (2000). Methylation of Class II trans-Activator Promoter IV: A Novel Mechanism of MHC Class II Gene Control. J. Immunol. 164: 4143-4149 [Abstract] [Full Text]  
  • Ghosh, N., Piskurich, J. F., Wright, G., Hassani, K., Ting, J. P.-Y., Wright, K. L. (1999). A Novel Element and a TEF-2-like Element Activate the Major Histocompatibility Complex Class II Transactivator in B-lymphocytes. J. Biol. Chem. 274: 32342-32350 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»